Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2009-9-21
pubmed:abstractText
Duloxetine is approved to treat diabetic peripheral neuropathic pain (DPNP) in the US. The study objective was to examine the predictors of duloxetine compliance, and its association with healthcare costs among DPNP patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1369-6998
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
192-202
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain.
pubmed:affiliation
Abt Bio-Pharma Solutions, Inc., Lexington, MA 02451, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't